Table 1 Sociodemographic and clinical characteristics of the Chinese patients with glaucoma

Number of participants

508

133(26.18)

306(60.24)

69(13.58)

Age (years)

55.41 ± 15.23

50.30 ± 16.07

57.22 ± 14.35

57.22 ± 15.32

<.01

<.01

0.01

1.00

Male gender

265(52.17)

65(48.87)

163(53.27)

37(53.62)

0.68

0.40

0.52

0.96

Duration of glaucoma (years)

5.06 ± 6.31

3.53 ± 4.32

5.14 ± 5.62

7.63 ± 10.40

<.01

0.04

<.01

0.01

Education

0.01

0.02

<.01

0.01

  Below primary/primary (≤6 years)

68(13.39)

11(8.27)

39(12.74)

18(26.09)

  Secondary (7–13 years)

253(49.80)

60(45.11)

160(52.29)

33(47.83)

  Tertiary (>13 years)

187(36.81)

62(46.62)

107(34.97)

18(26.09)

Living situation

0.76

0.57

0.48

0.74

  Family

471(92.72)

125(93.98)

283(92.48)

63(91.30)

  Alone

37(7.28)

8(6.02)

23(7.52)

6(8.70)

Economic status (RMB/month)

<.01

0.34

<.01

<.01

  <3000

65(12.80)

11(8.27)

36(11.77)

18(26.09)

  3000-5000

215(42.32)

57(42.86)

130(42.48)

28(40.58)

  >5000

228(44.88)

65(48.87)

140(45.75)

23(33.33)

Economic burden

0.01

0.27

<.01

0.04

  Light

124(24.41)

35(26.31)

74(24.18)

15(21.74)

  Moderate

255(50.20)

73(54.89)

157(51.31)

25(36.23)

  Heavy

129(25.39)

25(18.80)

75(24.51)

29(42.03)

Positive glaucoma family history

107(21.06)

30(22.56)

59(19.28)

18(26.09)

0.40

0.43

0.58

0.21

Type of glaucoma

0.05

0.03

0.28

0.23

  PACG

178(35.04)

35(26.32)

121(39.54)

22(31.88)

  POAG and NTG

264(51.97)

76(57.14)

147(48.04)

41(59.42)

  Secondary glaucoma

66(12.99)

22(16.54)

38(12.42)

6(8.70)

LogMAR HCVA in better eye

0.20 ± 0.37

0.06 ± 0.13

0.17 ± 0.25

0.59 ± 0.73

<.01

<.01

<.01

<.01

LogMAR HCVA in worse eye

0.80 ± 0.99

0.24 ± 0.29

0.86 ± 1.00

1.60 ± 1.15

<.01

<.01

<.01

<.01

MD in better eye

7.02 ± 6.62

1.20 ± 1.11

6.49 ± 3.53

20.57 ± 3.86

<.01

<.01

<.01

<.01

MD in worse eye

14.53 ± 8.79

4.91 ± 3.59

16.51 ± 7.36

24.32 ± 3.45

<.01

<.01

<.01

<.01

Period on using topical beta blocker (years)

1.04 ± 2.31

0.55 ± 1.37

1.00 ± 1.91

2.17 ± 4.25

<.01

0.17

<.01

<.01

Number of antiglaucoma medication used

1.57 ± 1.10

1.33 ± 0.93

1.54 ± 1.08

2.19 ± 1.25

<.01

0.17

<.01

<.01

Number of glaucoma surgery in treatment history

0.84 ± 1.07

0.56 ± 1.03

0.90 ± 1.02

1.12 ± 1.23

<.01

<.01

<.01

0.37

Number of laser intervention in glaucoma treatment

0.36 ± 0.78

0.39 ± 0.81

0.36 ± 0.74

0.30 ± 0.90

0.76

1.00

1.00

1.00

Higher IOP of both eyes

20.32 ± 9.49

18.08 ± 5.51

20.54 ± 9.86

23.68 ± 12.41

<.01

0.04

<.01

0.04